10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.85% | 23.16% | 191.14% | 42.69% | -0.16% |
| Total Depreciation and Amortization | 14.54% | 13.96% | -11.46% | -14.62% | -9.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.37% | -20.76% | -29.44% | -21.55% | -27.96% |
| Change in Net Operating Assets | 1,450.15% | 144.54% | -1,220.76% | 549.10% | -108.06% |
| Cash from Operations | 704.28% | 99.69% | 136.23% | 318.45% | -126.20% |
| Capital Expenditure | 34.57% | 82.33% | 45.17% | 34.95% | 21.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 101.28% | 85.24% | -95.69% | -- | -395.36% |
| Cash from Investing | 96.50% | -143.26% | -107.86% | -117.80% | -493.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -50.37% | 295.51% | -23.48% | -74.24% | -19.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.37% | 295.51% | -23.48% | -74.24% | -19.53% |
| Foreign Exchange rate Adjustments | 115.99% | -121.15% | 12,100.00% | 337.50% | -449.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 176.27% | 90.88% | -14.11% | 1,041.88% | -221.43% |